New combo therapy targets tough pancreatic tumors
Disease control
Not yet recruiting
This early-stage trial tests if combining radiation therapy with a new immunotherapy drug called PCX12 is safe for people with locally advanced pancreatic cancer. About 24 adults whose cancer has not spread after standard chemotherapy will receive radiation followed by injections…
Phase: PHASE1 • Sponsor: Haoming (Carl) Qiu • Aim: Disease control
Last updated May 03, 2026 10:55 UTC